The U.S. Department of Justice (DOJ) and Drug Enforcement Agency (DEA) have awarded Maridose LLC a federal license to supply cannabis flower, cannabis extracts and THC for research and pharmaceutical applications.
The licensure represents “a step toward ending” a decades-long monopoly that the University of Mississippi has had on cannabis grown for research, according to a press release.
Maridose will cultivate cannabis, conduct research and develop products at a center in Brunswick Landing, Maine, according to the release.
“We are very excited to receive this license from the DEA to produce and sell cannabis for research purpose, this a huge step for science and the future of cannabis,” Richard Shain, Maridose founder, said in a statement. “Our DEA Registration Number RM063095 is the culmination of over five years of working with the DEA and enables Maridose to legally sell a wide variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the United States and internationally.
“The DEA has indicated that it will only issue a very limited number of them, and Maridose is proud to be one of the first companies to receive a license. Cannabis businesses operating in states that have state legal cannabis are unable to ship across state lines and operate at legal risk because cannabis remains a Schedule 1 substance at the federal level. Maridose is able to legally supply our customers without these risks and limitations.”